Nikoletta Fotaki

Professor Nikoletta Fotaki is a faculty member in the Department of Life Sciences at the University of Bath, affiliated with the Centre for Therapeutic Innovation. She holds a PhD in Biopharmaceutics-Pharmacokinetics from the National and Kapodistrian University of Athens and has conducted postdoctoral research at Roche (USA). Her expertise focuses on oral drug absorption prediction, in vitro screening tools, and bioavailability assessment. She leads and collaborates on projects funded by the EU Horizon 2020, EPSRC, and Pharmacy Research UK, addressing drug development challenges in pediatric populations, bariatric surgery, and regulatory harmonization.

Education:

• B Pharm, National and Kapodistrian University of Athens (Greece)
• MSc Toxicology, University of Surrey (UK)
• PhD Biopharmaceutics-Pharmacokinetics, National and Kapodistrian University of Athens

Research Interests:

• Prediction of oral drug absorption via in vitro tools
• Physiologically Based Pharmacokinetic (PBPK) modeling
• Impact of gastrointestinal diseases on drug absorption
• Development of pediatric and long-acting injectable formulations
• Regulatory science and bioequivalence assessment

Recent Article Trends: Her 2024-2025 publications emphasize advanced PBPK modeling applications, pediatric pharmacokinetics, and innovative dissolution testing methods. Key themes include optimizing in vitro-in vivo correlations for complex drug delivery systems and integrating gut microbiota effects into pharmacokinetic models.

Grants & Projects:

• EU-H2020 PEARRL ITN (2016-2025): Training next-generation pharmaceutical scientists
• EPSRC-funded project (2024-2028): Enhancing NHS injectable drug delivery
• Pharmacy Research UK (2021-2026): Pharmacokinetic effects of bariatric surgery

Labs/Teams: Active in the Centre for Therapeutic Innovation, collaborating with global partners on drug development strategies and regulatory tools. Supervises doctoral students focusing on biopharmaceutics and drug delivery systems.